$3.82
At close: May 6 EDT
$3.82
0.000.00%
Pre-Market: 4:02 PM EDT
Comments
Loading...
Contineum Therapeutics Stock Guidance | NASDAQ:CTNM | Benzinga
Contineum Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Contineum Therapeutics Inc (CTNM) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Contineum Therapeutics (CTNM)?
There have been no specific sales or earnings guidance reported for Contineum Therapeutics in recent months.
Browse guidance and forecast on all stocks.
